Stocks · Health care · Pharmaceutical Preparations

Praxis Precision Medicines, Inc.

PRAX Clue Score27
United States Fiscal year ends December CIK 0001689548 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
837
$315.71
$264.25K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
1,279
$314.90
$402.76K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
504
$313.66
$158.09K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
1,004
$312.83
$314.08K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
2,854
$311.91
$890.20K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
1,750
$310.89
$544.06K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
999
$309.38
$309.07K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
1,240
$308.24
$382.22K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
683
$306.77
$209.52K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
320
$305.31
$97.70K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
120
$303.13
$36.38K
Jill DeSimone
24 Jun 2026
Director
Sold after exercise
10
$301.44
$3.01K
Lauren Mastrocola
20 Nov 2025
Principal Accounting Officer
Sold after exercise
2,145
$192.71
$413.37K
Lauren Mastrocola
20 Nov 2025
Principal Accounting Officer
Sold after exercise
11,455
$191.96
$2.20M
Alex Nemiroff
20 Nov 2025
General Counsel and Secretary
Sold after exercise
9,100
$194.30
$1.77M
Alex Nemiroff
20 Nov 2025
General Counsel and Secretary
Sold after exercise
977
$193.23
$188.79K
Alex Nemiroff
20 Nov 2025
General Counsel and Secretary
Sold after exercise
13,339
$192.53
$2.57M
Alex Nemiroff
20 Nov 2025
General Counsel and Secretary
Sold after exercise
1,714
$190.86
$327.14K
Lauren Mastrocola
14 Nov 2024
Principal Accounting Officer
Sold after exercise
5,188
$81.78
$424.32K
Alex Nemiroff
14 Nov 2024
General Counsel and Secretary
Sold after exercise
8,239
$80.20
$660.83K

What was left out

Form 4 filings counted 181
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 20
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 24,162,453
Sales filed before the plan box existed 11
History held since 20 Oct 2020